Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.
about
Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the artCompeting risk models to estimate the excess mortality and the first recurrent-event hazardsPredictors of competing mortality to invasive breast cancer incidence in the Canadian National Breast Screening study.Modelling competing risks in nephrology research: an example in peritoneal dialysis.A tutorial on sensitivity analyses in clinical trials: the what, why, when and how.Testing the treatment effect on competing causes of death in oncology clinical trialsDetrended Fluctuation Analysis of Heart Rate Dynamics Is an Important Prognostic Factor in Patients with End-Stage Renal Disease Receiving Peritoneal Dialysis.Epidemiological study of chronic kidney disease progression: a large-scale population-based cohort studyFine and Gray competing risk regression model to study the cause-specific under-five child mortality in Bangladesh.Competing Risk Analyses of Patients with End-Stage Renal Disease.Factors associated with initiation of chronic renal replacement therapy for patients with kidney failureDifferential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis.Prevalence of autosomal dominant polycystic kidney disease in the European Union.Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.
P2860
Q26827335-C358EF71-749D-4DA1-A8EF-DDC3C395B193Q33911799-2964E337-FD96-4DE8-BECC-C58E85DB13D9Q34343656-445B9E36-AA1B-4FD4-97DE-7358EF23CCEBQ34738940-563CB5C6-2D19-4C1A-8717-79C85CB14A3EQ34819923-2C727671-4113-41C2-8699-7EB1D018FAB4Q35177617-28DE2B1A-3A56-4DDB-8DBA-469741F49C57Q35909295-FC0118EE-8F89-4301-8B51-C09BA9DEAEFEQ36153299-DE73C218-D2C6-4483-8608-59CECD01D390Q36262932-D8DBA9B8-8834-4C6D-B0BE-B13E8A335B49Q36429234-A5D67D64-099E-4A65-9C65-A15963872BF6Q37065624-86B90CD5-A6FC-4983-A31B-013466D1A0E0Q37521459-8F08CA31-9311-43E7-847B-CA322C15BED6Q38871411-95532638-DE96-448A-815C-9435AA2A0568Q38938625-108EB447-8404-44AA-991B-31B67BD945E9Q40469080-C3A65C01-C008-4B5C-837A-DC10D8B0D276
P2860
Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Methods of competing risks ana ...... ty among people with diabetes.
@ast
Methods of competing risks ana ...... ty among people with diabetes.
@en
type
label
Methods of competing risks ana ...... ty among people with diabetes.
@ast
Methods of competing risks ana ...... ty among people with diabetes.
@en
prefLabel
Methods of competing risks ana ...... ty among people with diabetes.
@ast
Methods of competing risks ana ...... ty among people with diabetes.
@en
P2093
P2860
P356
P1476
Methods of competing risks ana ...... ty among people with diabetes.
@en
P2093
P2860
P2888
P356
10.1186/1471-2288-10-97
P577
2010-10-21T00:00:00Z
P5875
P6179
1040693479